[go: up one dir, main page]

MX2019000219A - Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida. - Google Patents

Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida.

Info

Publication number
MX2019000219A
MX2019000219A MX2019000219A MX2019000219A MX2019000219A MX 2019000219 A MX2019000219 A MX 2019000219A MX 2019000219 A MX2019000219 A MX 2019000219A MX 2019000219 A MX2019000219 A MX 2019000219A MX 2019000219 A MX2019000219 A MX 2019000219A
Authority
MX
Mexico
Prior art keywords
dosage form
oral dosage
form containing
exterior coating
fast release
Prior art date
Application number
MX2019000219A
Other languages
English (en)
Other versions
MX386983B (es
Inventor
Joseph Pulford Christopher
Original Assignee
Glaxosmithkline Consumer Healthcare Holdings Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Consumer Healthcare Holdings Us Llc filed Critical Glaxosmithkline Consumer Healthcare Holdings Us Llc
Publication of MX2019000219A publication Critical patent/MX2019000219A/es
Publication of MX386983B publication Critical patent/MX386983B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Aspectos de la presente invención se refieren a una forma de dosificación oral que comprende un núcleo que contiene uno o más ingredientes activos y un recubrimiento exterior de rápida liberación; el recubrimiento exterior de rápida liberación incluye un polímero soluble en agua; un alcohol de sacárido o azúcar, o una combinación de los mismos, y un saborizante; el saborizante puede ser un refrescante templado que es liberado en la cavidad oral del usuario después de insertar la forma de dosificación en su boca.
MX2019000219A 2016-07-05 2017-07-05 Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida MX386983B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662358223P 2016-07-05 2016-07-05
PCT/US2017/040655 WO2018009500A1 (en) 2016-07-05 2017-07-05 Oral dosage form containing a fast release exterior coating

Publications (2)

Publication Number Publication Date
MX2019000219A true MX2019000219A (es) 2019-09-04
MX386983B MX386983B (es) 2025-03-19

Family

ID=60892480

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000219A MX386983B (es) 2016-07-05 2017-07-05 Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida

Country Status (7)

Country Link
US (1) US11433037B2 (es)
EP (1) EP3481379A4 (es)
JP (1) JP2019524709A (es)
CN (1) CN109562075A (es)
CA (1) CA3029985A1 (es)
MX (1) MX386983B (es)
WO (1) WO2018009500A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220387328A1 (en) * 2021-06-04 2022-12-08 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Dosage form for nicotine replacement therapy
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789546A (en) 1987-02-19 1988-12-06 Consumer Products Corp. Multiple-layer tablet with contrasting organoleptic characteristics
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
US5098715A (en) * 1990-12-20 1992-03-24 Burroughs Wellcome Co. Flavored film-coated tablet
AU1655595A (en) * 1994-04-29 1995-11-09 Mcneil-Ppc, Inc. Solid pharmaceutical dosage form containing flavored film coating
EP0837862A1 (en) 1995-07-05 1998-04-29 The Procter & Gamble Company Warming compounds
US5807580A (en) * 1996-10-30 1998-09-15 Mcneil-Ppc, Inc. Film coated tablet compositions having enhanced disintegration characteristics
GB9707978D0 (en) 1997-04-21 1997-06-11 Procter & Gamble Throat soothing compositions
GB9707979D0 (en) 1997-04-21 1997-06-11 Procter & Gamble Confectionery compositions
AU7916798A (en) 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
GB2350046B (en) 1999-05-20 2002-12-18 British Sugar Plc Edible compositions containing trehalose
DE19962251A1 (de) 1999-12-22 2001-09-06 Hermes Fabrik Pharm Praeparate Lutschtablette
US6780443B1 (en) 2000-02-04 2004-08-24 Takasago International Corporation Sensate composition imparting initial sensation upon contact
US6365215B1 (en) 2000-11-09 2002-04-02 International Flavors & Fragrances Inc. Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
FR2832632B1 (fr) 2001-11-26 2004-04-23 Mane Fils V Capsule a solubilisation et liberation du contenu rapides
ATE386509T1 (de) * 2002-09-21 2008-03-15 Shuyi Zhang Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
WO2006020754A1 (en) 2004-08-11 2006-02-23 Cadbury Adams Usa Llc Sensate compositions and delivery systems therefor
BRPI0518553A2 (pt) * 2004-12-13 2008-11-25 Mcneil Ppc Inc composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada
US20070275135A1 (en) 2005-02-09 2007-11-29 First Flavor, Inc. Taste sampling process and product
US20050196517A1 (en) 2005-02-14 2005-09-08 Mars, Incorporated Edible product having discrete regions with different heats of solution
EP1874132A1 (en) 2005-04-15 2008-01-09 Firmenich Sa Hot flavour and skin sensation composition
WO2006136196A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070036733A1 (en) 2005-08-12 2007-02-15 Takasago International Corp. (Usa) Sensation masking composition
EP1973422B1 (en) 2005-12-23 2014-06-11 Intercontinental Great Brands LLC Compositions providing a heating sensation for oral or dermal delivery
US20070224258A1 (en) * 2006-03-22 2007-09-27 Bunick Frank J Dosage forms having a randomized coating
US20070231387A1 (en) * 2006-04-04 2007-10-04 Luigi Levi Film-coated solid dosage forms
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
US20080317677A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
KR20100119539A (ko) * 2007-12-10 2010-11-09 유란드, 인코포레이티드 다이펜하이드라민을 포함하는 경구 분해성 정제
ES2425356T3 (es) 2008-04-15 2013-10-14 Firmenich S.A. Composición sensorial de calidez
CN101612144A (zh) * 2008-05-19 2009-12-30 张书毅 含对乙酰氨基酚和曲马多的缓释制剂
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2011002702A1 (en) * 2009-06-29 2011-01-06 Mcneil-Ppc, Inc. Pharmaceutical tablet containing a liquid filled capsule
BR112012010170A2 (pt) 2009-10-28 2016-04-12 Mcneil Ppc Inc composições de revestimento para desintegração/dissolução rápida
PH12012502463A1 (en) 2010-06-30 2019-06-03 Colgate Palmolive Co Multilayer films for delivery of flavor
US9421171B2 (en) 2011-02-14 2016-08-23 The Procter & Gamble Company Coated solid dosage forms
CA2834231A1 (en) 2011-04-28 2012-11-01 Acme Specialty Products, Llc Taste masking compositions and edible forms thereof
US20130177646A1 (en) 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US20140010768A1 (en) 2012-07-09 2014-01-09 Wild Flavors, Inc. Flavoring ingredient in oral compositions
US20140079740A1 (en) * 2012-08-02 2014-03-20 ClinPharm Support GmbH Oral transmucosal adminstration forms of s-ketamine

Also Published As

Publication number Publication date
MX386983B (es) 2025-03-19
CA3029985A1 (en) 2018-01-11
BR112019000282A2 (pt) 2019-04-16
CN109562075A (zh) 2019-04-02
EP3481379A1 (en) 2019-05-15
RU2019102920A3 (es) 2020-08-28
US20180008562A1 (en) 2018-01-11
WO2018009500A1 (en) 2018-01-11
US11433037B2 (en) 2022-09-06
RU2019102920A (ru) 2020-08-06
EP3481379A4 (en) 2020-03-11
JP2019524709A (ja) 2019-09-05

Similar Documents

Publication Publication Date Title
MX2021006035A (es) Formulaciones cannabinoides estables.
MX2015008983A (es) Pelicula comestible soluble en agua.
AR089670A1 (es) Forma de dosificacion que comprende nicotina solida con reduccion de los trastornos organolepticos
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
MX2012003551A (es) Tabletas transformables via oral.
PE20151301A1 (es) Formulaciones farmaceuticas resistentes a la manipulacion indebida
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
MX2020005942A (es) Delgada pelicula oral con alta carga de agente activo.
CL2012002115A1 (es) Una pastilla blanda que comprende nicotina, gelificante, platificante, edulcorante, agente liberador, conservante, saborizante, agua y es capaz de disolverse en la cavidad bucal en un periodo de 5 y 15 minutos; y proceso de preparacion.
BR112016002251A2 (pt) dispositivo para administração de fármacos
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
BR112015030140A2 (pt) forma de dosagem farmacêutica sólida para liberação de pelo menos um ingrediente farmacêutico ativo na cavidade oral
DOP2017000307A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma.
PE20191149A1 (es) Uso farmaceutico de una composicion que contiene pirfenidona de liberacion prolongada (pfd-lp) para la reversion y tratamiento de la esteatohepatitis humana (nafld/nash)
CA2982902A1 (en) Dental suction arrangement
AR102780A1 (es) Composiciones farmacéuticas, su preparación y sus usos
MX2019000219A (es) Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida.
CR20150567A (es) Revestimientos reticulados suministrados mediante un balón
CO2018002428A2 (es) Amida seleccionada de ácido gamma-hidroxiburico y usos de la misma en el tratamiento de abuso de alcohol
MX2015013934A (es) Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea.
MX2019004938A (es) Cápsula compleja que contiene esomeprazol y método de preparación de esta.
PH12016502059A1 (en) Fast dissolving granulate
AR093707A1 (es) Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5
ES2475942B1 (es) Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa
CO2019004796A2 (es) Preparación de complejo farmacéutica que comprende amlodipina, losartán y rosuvastatina